Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and independent use of tadalafil 10 mg for erectile dysfunction
2019-003073-25Phase 4Completed
- Sponsor
- Adamed Pharma
- Start
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of tadalafil in erectile dysfunction (ED), sponsored by Adamed Pharma. Primary endpoint: Primary: Safe independent decision-making on tadalafil 10 mg use. Started Sep 2019; status: completed.
02
Drugs
tadalafil
03
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on 2019-003073-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-003073-25.